Literature DB >> 1965241

Severe hyponatremia: an association with lisinopril?

A L Hume1, B W Jack, P Levinson.   

Abstract

A 63-year-old white woman with a history of hypertension and chronic obstructive pulmonary disease presented to the emergency room with worsening shortness of breath, anorexia, coughing, increased thirst, and leg edema of two weeks' duration. Medications included lisinopril 10 mg/d, which had been started six weeks earlier, sustained-release theophylline 300 mg q12h, and an albuterol inhaler. The lisinopril was discontinued on admission. Serum sodium concentration was 109 mmol/L; the osmolality of the blood and of the urine were 253 mOsmol and 438 mOsmol, respectively, with a specific gravity of 1.025 and a urine sodium of 17 mmol/L. The hyponatremia initially was considered to be the syndrome of inappropriate antidiuretic hormone secretion in response to the patient's suspected pneumonia. Due to worsening blood pressure, lisinopril was restarted and the serum sodium concentration dropped from 134 to 126 mmol/L. Evaluation of the patient's hyponatremia included assessment of thyroid, adrenal, hepatic, and cardiac function that were within normal limits. The patient was discharged on the following medications: sustained-release theophylline 300 mg tid, prednisone 10 mg/d, albuterol inhaler 2 puffs q6h, and sustained-release verapamil 240 mg/d for blood pressure control. Her serum sodium concentration has remained between 135 and 140 mmol/L during hospitalizations for exacerbations of chronic obstructive pulmonary disease and for pneumonias 10 and 12 months after discharge.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965241     DOI: 10.1177/106002809002401204

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  6 in total

Review 1.  Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.

Authors:  K L Goa; J A Balfour; G Zuanetti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

2.  Hyponatraemia associated with paroxetine.

Authors:  T P Chua; S K Vong
Journal:  BMJ       Date:  1993-01-09

3.  Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients: a single-center experience in Turkey.

Authors:  K Turgutalp; O Ozhan; E Gok Oguz; M Horoz; A Camsari; A Yilmaz; A Kiykim; M Arici
Journal:  Int Urol Nephrol       Date:  2012-10-11       Impact factor: 2.370

Review 4.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

5.  Prevalence of hyponatremia and association with mortality: results from NHANES.

Authors:  Sumit Mohan; Sue Gu; Amay Parikh; Jai Radhakrishnan
Journal:  Am J Med       Date:  2013-12       Impact factor: 4.965

6.  Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism.

Authors:  Lijuan Yang; Xiuqin Sun; Yi Zhao; Hong Tao
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.